NORMAL SITUATION

PHARMACIE DAVOINE

Export PDF

Company — Normal situation.

Financial year 2021 · Closed on 31/12/2021

Net result8,1 k €+124,5 %over 1 year

Gross margin74,2 k €-26,3 %over 1 year

Equity205,8 k €+4,1 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE DAVOINE is a company registered in Belgium.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0446.871.377
Legal form: Public limited company
Contributed capital: 61 500,00 €
Latest accounts: 31/12/2021

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 30 filings

Trend over 16 financial years

	2021		2020		2019		2018		2017
Income statement
Gross margin	74,2 k €	-26.3%	100,7 k €	-10.3%	112,3 k €	-29.7%	159,8 k €	+4.3%	153,2 k €
EBITDA	18,3 k €	+490%	-4,7 k €	-144%	10,6 k €	-78.5%	49,4 k €	+13.7%	43,5 k €
Operating result	8,6 k €	+128%	-30,7 k €	-92.2%	-16 k €	-170%	22,8 k €	+41.4%	16,2 k €
Net result	8,1 k €	+125%	-33 k €	-73.7%	-19 k €	-239%	13,7 k €	+96.1%	7 k €
Balance sheet
Equity	205,8 k €	+4.1%	197,7 k €	-14.3%	230,7 k €	-7.6%	249,7 k €	+5.8%	236,1 k €
Total assets	267,6 k €	-6.2%	285,2 k €	-15.3%	336,8 k €	-9.2%	370,9 k €	-9.2%	408,6 k €
Cash	114,5 k €	+38.7%	82,5 k €	-22.2%	106,1 k €	-4.0%	110,5 k €	+42.2%	77,7 k €
Debts	61 k €	-30.3%	87,5 k €	-17.5%	106 k €	-12.5%	121,2 k €	-29.8%	172,6 k €
Other
Workforce	–		2,8 ETP	+16.7%	2,4 ETP	-14.3%	2,8 ETP	0.0%	2,8 ETP

Board of directors

Source · NBB, accounts to 31/12/2021

1 active · 15 ended

Active mandates

BINCHE PHARMA

Director · 0767.986.810

Represented by FRANCOIS VANLAUTEM

Active

Ended mandates

GINETTE LAMBRECHT

Director · since 09 juin 2017 · until 09 juin 2023

Ended

PATRICK HAVELANGE

Director · since 09 juin 2017 · until 09 juin 2023

Ended

VERONIQUE DAVOINE

Managing director · since 09 juin 2017 · until 09 juin 2023

Ended

GINETTE LAMBRECHT

Director · since 10 juin 2011 · until 09 juin 2017

Ended

Full financial information

Source · NBB

	2021	2020	2019	2018	2017	2016
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/12/2022	01/07/2021	29/06/2020	17/06/2019	16/07/2018	19/07/2017
General meeting	14/10/2022	11/06/2021	12/06/2020	14/06/2019	08/06/2018	09/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 30 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2021	14/10/2022	31/12/2022	French	PDF
Abridged model	31/12/2020	11/06/2021	01/07/2021	French	PDF
Abridged model	31/12/2019	12/06/2020	29/06/2020	French	PDF
Abridged model	31/12/2018	14/06/2019	17/06/2019	French	PDF
Abridged model	31/12/2017	08/06/2018	16/07/2018	French	PDF
Abridged model	31/12/2016	09/06/2017	19/07/2017	French	PDF
Abridged model	31/12/2015	10/06/2016	01/08/2016	French	PDF
Abridged model	31/12/2014	12/06/2015	28/08/2015	French	PDF
Abridged model	31/12/2013	13/06/2014	09/07/2014	French	PDF
Abridged model	31/12/2012	14/06/2013	06/08/2013	French	PDF
Abridged model	31/12/2011	08/06/2012	19/07/2012	French	PDF
Abridged model	31/12/2010	10/06/2011	20/07/2011	French	PDF
Abridged model	31/12/2009	11/06/2010	05/07/2010	French	PDF
Abridged model	31/12/2008	24/06/2009	03/07/2009	French	PDF
Abridged model	31/12/2007	16/06/2008	04/07/2008	French	PDF
Abridged model	31/12/2006	08/06/2007	29/06/2007	French	PDF
Abridged model	31/12/2005	10/06/2006	19/06/2006	French	PDF
Abridged model	31/12/2004	10/06/2005	16/06/2005	French	PDF
Abridged model	31/12/2003	18/06/2004	02/07/2004	French	PDF
Abridged model	31/12/2002	13/06/2003	04/07/2003	French	PDF
Abridged model	31/12/2001	15/06/2002	01/07/2002	French	PDF
Abridged model	31/12/2000	11/05/2001	16/05/2001	French	PDF
Abridged model	31/12/1999	09/06/2000	20/06/2000	French	PDF
Abridged model	31/12/1998	10/09/1999	23/09/1999	French	PDF

View all 30 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2021

1 active · 15 ended

Active mandates

BINCHE PHARMA

Director · 0767.986.810

Represented by FRANCOIS VANLAUTEM

Active

Ended mandates

GINETTE LAMBRECHT

Director · since 09 juin 2017 · until 09 juin 2023

Ended

PATRICK HAVELANGE

Director · since 09 juin 2017 · until 09 juin 2023

Ended

VERONIQUE DAVOINE

Managing director · since 09 juin 2017 · until 09 juin 2023

Ended

GINETTE LAMBRECHT

Director · since 10 juin 2011 · until 09 juin 2017

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Dissolution26/08/2022
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
PDF
Restructuring05/11/2021
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates28/07/2021
DEMISSIONS, NOMINATIONS - CAPITAL, ACTIONS - SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
PDF
Mandates12/07/2017
DEMISSIONS, NOMINATIONS
PDF
Mandates18/10/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates29/07/2005
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - ASSEMBLEE GENERALE
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2021
Annual accounts 20218,1 k €↑
2020
Annual accounts 2020-33 k €↓
2019
Annual accounts 2019-19 k €↓
2018
Annual accounts 201813,7 k €↑
2017
Annual accounts 20177 k €↓
2016
Annual accounts 201637,4 k €↑
2015
Annual accounts 201534,2 k €↓
2014
Annual accounts 201470,4 k €↑
2013
Annual accounts 201322,5 k €↓
2012
Annual accounts 201225,8 k €↓
2011
Annual accounts 201125,9 k €↑
2010
Annual accounts 201011,5 k €↓
2009
Annual accounts 200916,8 k €↓
2008
Annual accounts 200830,7 k €↑
2007
Annual accounts 200725,1 k €↑
2006
Annual accounts 200622 k €

PHARMACIE DAVOINE

Overview

Identity

Financials

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline